Blood Testing Market is expected to witness 7.3% CAGR between 2021-2031- Market Insights, Size, Share, Growth, Analysis, and Forecast

According to a new market research report published by sheer analytics and insights, “The Global Blood Testing Market was valued at $70.3 Billion in 2020. Growing at a high CAGR of more than 7.3% between 2021 and 2031, it is estimated to reach $160.4 Billion by 2031, as per the latest market research report titled Global Blood Testing Market – Industry analysis, size, share, growth, trends, and forecast, 2021-2031.

The blood test is the process of collecting the blood sample and analyzing it in a laboratory. The blood is generally drawn for any testing using a needle from a vein in one of the arms. Sometimes a finger is enough to pricked and draw blood for testing. Generally, Blood testing is done to conclude the status of the health of a person. Blood tests are generally utilized in the healthcare sector to ascertain organ function, disease spread, pharmaceutical drugs’ effectiveness, and physiological and biochemical states. Rising demand and importance for blood testing are expected to encourage the global blood testing market’s growth in the years to come. The increasing prevalence of objective diseases such as COVID-19 cardiovascular diseases and diabetes are the factor for market growth during the forecast period.

Get Sample Copy With Covid19 Impact Analysis:

However, in this current pandemic of COVID-19, the Blood Testing market is affected much. It changes the growth rate graph slightly in the Blood Testing market. The investment and number of testing are increasing rapidly after the outbreak of this current pandemic.  Apart from that, the Blood Testing sector’s rising across the world is anticipated to offer a massive opportunity for market growth in the next forecast period of 2021 to 2031.

The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc., Roche Diagnostics, Quest Diagnostics, Danaher Corporation, Becton Dickinson & Company, Biomerica, Inc., bioMérieux S.A., Siemens Healthcare, Trinity Biotech PLC, Baxter International, Cepheid Corporation, Hoffmann-La Roche AG, Novartis International AG, and Thermo Fisher Scientific among others.

Browse the Full report at

The Global Blood Testing Market Has Been Segmented into:

By Type

  • Glucose
  • A1C
  • Direct LDL
  • Lipid panel
  • Prostate-specific antigen
  • COVID-19
  • BUN
  • Vitamin D
  • Thyroid-stimulating hormone
  • Serum Nicotine / Cotinine
  • High sensitivity CRP
  • Testosterone
  • ALT
  • Cortisol
  • Creatinine
  • AST
  • Other tests

By Method

  • Manual Blood Testing
  • Automated Blood Testing

By End-User

  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

By Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA 

About Us:

Sheer Analytics and Insights as firm is created to balance between client requirements without compromising the core values of Market research in –terms of quality, factual correctness, market awareness and analysis. SAI goes back to the root of Market Research in terms of TAM (Total Available Market) and PAM (Potential Available Market) and assess the same quantifying all Push and Pull factors.

Contact us:

Name: Abhigyan Sengupta

(Global sales Manager)

Ph.: +1-414-240-5010 (U.S.)



Leave a Reply

Your email address will not be published. Required fields are marked *